Showing 1 to 1 of 1 results
forbes.com
🌐 85% Global Worthiness


Decreased Insurance Coverage for GLP-1 Agonists Amidst Soaring Demand
Between 2024 and 2025, insurance coverage for Ozempic dropped 22%, affecting 1.1 million people, while Zepbound saw a 14% increase in uninsured individuals (4.9 million), despite a 300% rise in Zepbound fills and doubled Ozempic fills since early 2024, highlighting the rising cost of these medicatio...
Decreased Insurance Coverage for GLP-1 Agonists Amidst Soaring Demand
Between 2024 and 2025, insurance coverage for Ozempic dropped 22%, affecting 1.1 million people, while Zepbound saw a 14% increase in uninsured individuals (4.9 million), despite a 300% rise in Zepbound fills and doubled Ozempic fills since early 2024, highlighting the rising cost of these medicatio...
Progress
36% Bias Score
Good Health and Well-being
Showing 1 to 1 of 1 results